The Food and Drug Administration on Wednesday approved a new drug called ATX-101, which has caused a buzz in the cosmetic industry.

The recently approved drug targets the area on some face known as double chin. So if anyone faces the similar issue of double chin the new drug can do wonders.

As per doctors, the fat cells get accumulated below your chin due to weight gain or genetics. This fat accumulation makes it appear you have two, three, or even more chins.

Dr. Prichard, head of plastic surgery at John C. Lincoln Hospital, said ATX-101 or Kybella is the new injectable drug that was approved by the FDA.

The drug maker Kyrthera on its website stated that double chin patients treated with the drug have had success in removing the fat.

"It actually dissolves the membranes in the fat cells, and once the fat cell doesn't have the membrane around it, it just dies, and all of that fat gets excreted and treated in the liver, it goes back into circulation and removes it from this specific spot", said Prichard.

The charges for the treatment are estimated to be about $2,000 per treatment. The before and after result photos of the people on whom the treatment was done showed results after 5-6 treatments. Charges for five treatments would cost total of over $10,000.

Prichard said there are some patients who would need only one treatment in order to get rid of their double chin.

He elaborated that if a person has just a little bit of double chin, then he or she would require only one treatment.

KYBELLA is the first and only approved non-surgical treatment for reduction of sub-mental fullness, a common yet under-treated aesthetic condition.